During the George W. Bush administration, the Centers for Medicare and Medicaid Services (CMS) introduced a program known as “Coverage with Evidence Development” (CED) to drive innovation for medical devices by increasing access to new technologies through agency-approved clinical trials. In practice, it has had much the opposite effect, creating barriers that prevent wider access to medical breakthroughs, limiting data for research, and ultimately hampering innovation.
Read Full Article »
